In Vivo Delivery of Nucleic Acid-Formulated Microparticles as a Potential Tolerogenic Vaccine for Type 1 Diabetes . (2023). The Review of Diabetic Studies , 9(4). https://diabeticstudies.org/index.php/RDS/article/view/184